Rapid determination of plasmonic nanoparticle agglomeration status in blood.

导出 OA

翻译打印收藏纠错

作者： Samir V,Jenkins ^[1] ; Haiou,Qu ^[2] ; Thilak,Mudalige ^[2] ; Taylor M,Ingle ^[3] ; Rongrong,Wang ^[4] ; Feng,Wang ^[5] ; Paul C,Howard ^[3] ; Jingyi,Chen ^[5] ; Yongbin,Zhang ^[6]

作者单位： NCTR/ORA Nanotechnology Core Facility, U.S. Food and Drug Administration, Jefferson, AR 72079, United States; Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, United States. ^[1] NCTR/ORA Nanotechnology Core Facility, U.S. Food and Drug Administration, Jefferson, AR 72079, United States; Arkansas Regional Laboratory, Office of Regulatory Affairs, U.S. Food and Drug Administration, Jefferson, AR 72079, United States. ^[2] NCTR/ORA Nanotechnology Core Facility, U.S. Food and Drug Administration, Jefferson, AR 72079, United States; Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States. ^[3] NCTR/ORA Nanotechnology Core Facility, U.S. Food and Drug Administration, Jefferson, AR 72079, United States; Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States; Hunan Province of Food and Drug Control, Changsha, Hunan 410001, China. ^[4] Department of Chemistry and Biochemistry, University of Arkansas, Fayetteville, AR 72701, United States. ^[5] NCTR/ORA Nanotechnology Core Facility, U.S. Food and Drug Administration, Jefferson, AR 72079, United States; Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States. Electronic address: Yongbin.Zhang@fda.hhs.gov. ^[6]

关键词 Blood Darkfield microscopy Gold Nanoparticles Silver Single particle ICP-MS